Pages Menu
FacebookTwitterPinterestRss
Categories Menu

Posted by on Oct 5, 2016 in Foundation NewsLine, Type C |

Vtesse Announces Dosing of First Patient in Germany

VTESSE PRESS RELEASE

Vtesse Announces Dosing of First Patient in
Germany for Phase 2b/3 Clinical Trial of VTS-270
in Niemann-Pick Type C1 Disease

CLICK HERE FOR FULL RELEASE

10/05/2016 jjb